Skip to main content
Home

Top menu InfoLep

  • About InfoLep


Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2023
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Publications
  • Practical materials
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Refine your results

Refine your results


Selected filters

  • Reset filters
  • Article
  • South-East Asia Region (SEAR)

Filter by type

  • Publications

NTD

  • Leprosy (Hansen disease) (8)

Subject

  • Tuberculosis (1)
  • Reversal reaction (Type 1 reaction) (1)
  • HIV/AIDS (1)
  • Erythema nodosum leprosum - enl (Type 2 reaction) (1)
  • Complications and reactions (2)

Resource type

  • (-) Article (8)
  • Full text online (5)

Target audience

Journal

  • BMC infectious diseases (1)
  • Cytokine (2)
  • Frontiers in immunology (1)
  • Journal of immunoassay & immunochemistry (1)
  • Molecular immunology (1)
  • Open Forum Infectious Diseases (1)
  • PLoS neglected tropical diseases (1)

Year of Publication

  • 2020 (1)
  • 2019 (3)
  • 2017 (1)
  • 2016 (1)
  • 2015 (1)
  • 2013 (1)

Language

  • English (8)

Regional focus

  • (-) South-East Asia Region (SEAR) (8)
    • India (7)
 
  • Relevance
  • Date
8 items

Publication

Association of IL-10 Gene Polymorphism With IL-10 Secretion by CD4 and T Regulatory Cells in Human Leprosy.

Tarique M, Naz H, Saini C, et al. Frontiers in immunology. 2020;
Download PDF

Publication

A distinct double positive IL-17A/F T helper 17 cells induced inflammation leads to IL17 producing neutrophils in Type 1 reaction of leprosy patients.

Saini C, Srivastava R, Kumar P, et al. Cytokine. 2019;

Publication

Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.

Upadhyay R, Dua B, Sharma B, et al. BMC infectious diseases. 2019; 19 (1) : 52.
Download PDF

Publication

CD4+, CD8+, CD3+ cell counts and CD4+/CD8+ ratio among patients with mycobacterial diseases (Leprosy, Tuberculosis), HIV infections and Normal Healthy Adults : A comparative analysis of studies in different regions of India.

Hussain T, Kulshreshtha K K, Yadav V S, et al. Journal of immunoassay & immunochemistry. 2015; 36 (4) : 420-443.
Download PDF

Publication

Increased IL-35 producing Tregs and CD19(+)IL-35(+) cells are associated with disease progression in leprosy patients.

Tarique M, Saini C, Naqvi RA, et al. Cytokine. 2016;

Publication

IL-12 and IL-23 modulate plasticity of FoxP3(+) regulatory T cells in human Leprosy.

Tarique M, Saini C, Naqvi RA, et al. Molecular immunology. 2017;

Publication

CD4+ Th17 cells discriminate clinical types and constitute a third subset of non Th1, Non Th2 T cells in human leprosy.

Saini C, Ramesh V, Nath I. PLoS neglected tropical diseases. 2013; 7 (7) : e2338.
Download PDF

Publication

1345. randomized control trial to evaluate the clinical and cytokine response profile to oral Thalidomide in leprosy patients with erythema nodosum leprosum

Chopra A, Mitra D. Open Forum Infectious Diseases. 2019;
Download PDF

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2023 InfoNTD